791 related articles for article (PubMed ID: 10337451)
1. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
2. The effect of pravastatin and atorvastatin on coenzyme Q10.
Bleske BE; Willis RA; Anthony M; Casselberry N; Datwani M; Uhley VE; Secontine SG; Shea MJ
Am Heart J; 2001 Aug; 142(2):E2. PubMed ID: 11479481
[TBL] [Abstract][Full Text] [Related]
3. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin-induced lactic acidosis: a rare adverse reaction?
Goli AK; Goli SA; Byrd RP; Roy TM
Clin Pharmacol Ther; 2002 Oct; 72(4):461-4. PubMed ID: 12386648
[TBL] [Abstract][Full Text] [Related]
5. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
6. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
7. [Effect of cholesterol reducing therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on secondary prevention after myocardial infarction in Japanese patients].
Tachibana E; Watanabe I; Nagao K; Kanmatsuse K
J Cardiol; 2000 Apr; 35(4):277-85. PubMed ID: 10791271
[TBL] [Abstract][Full Text] [Related]
8. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats.
Modi K; Santani DD; Goyal RK; Bhatt PA
Biol Trace Elem Res; 2006 Jan; 109(1):25-34. PubMed ID: 16388100
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors and coenzyme Q10.
Nawarskas JJ
Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.
Takahashi T; Ishii N; Itai K; Goto R; Higashi K; Kobori S
J Atheroscler Thromb; 2005; 12(3):149-53. PubMed ID: 16020915
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Chikamori T; Sugimoto K; Hamada T; Kitaoka H; Furuno T; Seo H; Doi Y
J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients.
Liu CS; Lii CK; Chang LL; Kuo CL; Cheng WL; Su SL; Tsai CW; Chen HW
Nutr Res; 2010 Feb; 30(2):118-24. PubMed ID: 20226997
[TBL] [Abstract][Full Text] [Related]
13. The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats.
Kuzelová M; Adameová A; Sumbalová Z; Paulíková I; Harcárová A; Svec P; Kucharská J
Gen Physiol Biophys; 2008 Dec; 27(4):291-8. PubMed ID: 19202203
[TBL] [Abstract][Full Text] [Related]
14. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.
Berthold HK; Naini A; Di Mauro S; Hallikainen M; Gylling H; Krone W; Gouni-Berthold I
Drug Saf; 2006; 29(8):703-12. PubMed ID: 16872244
[TBL] [Abstract][Full Text] [Related]
15. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.
Ghirlanda G; Oradei A; Manto A; Lippa S; Uccioli L; Caputo S; Greco AV; Littarru GP
J Clin Pharmacol; 1993 Mar; 33(3):226-9. PubMed ID: 8463436
[TBL] [Abstract][Full Text] [Related]
16. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
Mortensen SA; Leth A; Agner E; Rohde M
Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
[TBL] [Abstract][Full Text] [Related]
18. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
Branchi A; Rovellini A; Fiorenza AM; Sommariva D
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
[TBL] [Abstract][Full Text] [Related]
19. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
[TBL] [Abstract][Full Text] [Related]
20. [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism].
Rákóczi K; Párdutz A; Vécsei L
Ideggyogy Sz; 2007 Jul; 60(7-8):295-300. PubMed ID: 17713110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
